Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development
- PMID: 10341287
- DOI: 10.3892/ijmm.3.6.585
Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development
Abstract
In neuroblastoma, a childhood tumor of neural crest, a tumor suppressor gene located at 1p36 has been implicated to play a major role in tumor aggressiveness and clinical prognosis. We have examined 30 different staged primary neuroblastoma tumors using RT-PCR, for expression of the p73 gene located at 1p36.3, and its correlation to other clinical and biological features of these tumors. No correlation between expression of p73 and MYCN-amplification or 1p-deletion could be found, five of ten 1p-deleted tumors showed detectable levels of p73, and no mutations could be detected, neither in the retained alleles nor in any other parts of the material. In five 1p-deleted cases the origin of deletion were determined, two were of maternal and three of paternal origin. Both tumors with maternal 1p-loss showed detectable levels of p73, whereas the three with paternal loss did not. This suggests that p73 is expressed from the paternal allele only in advanced staged neuroblastoma tumors. Furthermore, it suggests absence of correlation between p73-expression and stage in these tumors. In conclusion, we could find no evidence for p73 being the neuroblastoma tumor suppressor gene in 1p36.
Similar articles
-
N-myc modulates expression of p73 in neuroblastoma.Neoplasia. 2002 Sep-Oct;4(5):432-9. doi: 10.1038/sj.neo.7900255. Neoplasia. 2002. PMID: 12192602 Free PMC article.
-
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.Oncogene. 1999 Jan 28;18(4):1061-6. doi: 10.1038/sj.onc.1202390. Oncogene. 1999. PMID: 10023682
-
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.Cell. 1997 Aug 22;90(4):809-19. doi: 10.1016/s0092-8674(00)80540-1. Cell. 1997. PMID: 9288759
-
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.Med Pediatr Oncol. 2001 Jan;36(1):52-5. doi: 10.1002/1096-911X(20010101)36:1<52::AID-MPO1014>3.0.CO;2-8. Med Pediatr Oncol. 2001. PMID: 11464906 Review.
-
Biological and clinical role of p73 in neuroblastoma.Cancer Lett. 2003 Jul 18;197(1-2):111-7. doi: 10.1016/s0304-3835(03)00092-2. Cancer Lett. 2003. PMID: 12880969 Review.
Cited by
-
Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.Br J Cancer. 2002 Feb 12;86(4):596-604. doi: 10.1038/sj.bjc.6600111. Br J Cancer. 2002. PMID: 11870543 Free PMC article.
-
1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours.J Neurooncol. 2011 Jul;103(3):409-16. doi: 10.1007/s11060-010-0422-3. Epub 2010 Sep 29. J Neurooncol. 2011. PMID: 20878447
-
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.BMC Cancer. 2005 Dec 16;5:161. doi: 10.1186/1471-2407-5-161. BMC Cancer. 2005. PMID: 16359544 Free PMC article.
-
N-myc modulates expression of p73 in neuroblastoma.Neoplasia. 2002 Sep-Oct;4(5):432-9. doi: 10.1038/sj.neo.7900255. Neoplasia. 2002. PMID: 12192602 Free PMC article.
-
Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cells.Sci Rep. 2020 Jan 23;10(1):1046. doi: 10.1038/s41598-020-57854-6. Sci Rep. 2020. PMID: 31974512 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical